Joseph Souza, MD
Clinical Cardiac Electrophysiology · Lexington, KYNPI 1336145457
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $76,850 of the $110,186 with a category attached, or 69.7%. 23 manufacturers reported payments, led by Medtronic at 47.1% of the total. Reporting peaked in 2019 at $55,573 and has fallen 98.2% since, to $990 in 2025.
Across 339 payments — averaging $325.03 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medtronic$52K
- Johnson & Johnson$50K
- Abbott$4K
- Philips North America LLC$1K
- Altathera Pharmaceuticals LLC$944
- Atricure, Inc.$463
- plus $2K from 17 others
Across 61 payments — averaging $1538.65 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Medtronic$90K
- Abbott$4K
What the payments were for
- Consulting fees$9,6009%
- Speaking & faculty fees$76,85070%
- Travel & lodging$9,4909%
- Food & beverage$14,23213%
- Education$140%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medtronic(2 entities) | 169 | $51,950 |
| Johnson & Johnson | 31 | $49,828 |
| Abbott | 43 | $3,901 |
| Philips North America LLC | 21 | $1,305 |
| Altathera Pharmaceuticals LLC | 2 | $944 |
| Atricure, Inc. | 9 | $463 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 13 | $365 |
| Boston Scientific | 13 | $345 |
| Biotronik Inc. | 4 | $327 |
| Boehringer Ingelheim | 8 | $254 |
| Pfizer | 12 | $187 |
| Edwards Lifesciences | 1 | $62 |
| Biosense Webster, Inc. | 1 | $39 |
| Novartis | 2 | $36 |
| United Therapeutics Corporation | 2 | $34 |
| E.r. Squibb & Sons, L.L.C. | 1 | $33 |
| Inspire Medical Systems, Inc. | 1 | $22 |
| Alnylam Pharmaceuticals Inc. | 1 | $18 |
| Daiichi Sankyo Inc. | 1 | $17 |
| Cardiva Medical, Inc. | 1 | $15 |
| Kls-martin L.p. | 1 | $14 |
| Actelion Pharmaceuticals US, Inc. | 1 | $14 |
| Chiesi USA, Inc. | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- XARELTO$49,303
- Arctic Front$16,852
- DiamondTemp$1,968
- PulseSelect$1,767
- CardioInsight$1,140
- Allure Quadra RF CRT Pacemaker$1,000
- Ensite Cardiac Mapping System$948
- Sotalol Hydrochloride$850
- Micra$645
- Confirm Rx$639
- CryoConsole$294
- (9124) LM Undivided$286
- SelectSecure$225
- CARDIOMEMS$154
- LINQ II$123
- ENSITE$114
- ENSITE PRECISION$114
- Rivacor 7 DR-T$108
- Acticor 7 VR-T DX$108
- BioMonitor$108
How this compares
$110,186 in reported general payments places this provider in the 85th percentile of 57 clinical cardiac electrophysiology providers in Kentucky.
See all clinical cardiac electrophysiology providers in Kentucky →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 83 | $70,999 |
| XareltoRivaroxaban | 12 | $14,279 |
| Flecainide Acetate | 18 | $666 |
| Metoprolol Succinate | 37 | $577 |
| Amiodarone Hcl | 39 | $542 |
| Diltiazem 24hr Er (Cd)Diltiazem Hcl | 14 | $226 |
| Doxycycline Hyclate | 34 | $152 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 32 | $121 |
| Carvedilol | 17 | $34 |
| Cephalexin | 14 | $24 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerEliquis | $187 | $70,99983 claims |
| Johnson & JohnsonXarelto | $49,828 | $14,27912 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 57 clinical cardiac electrophysiology providers in Kentucky.
Other clinical cardiac electrophysiology in Lexington
- Johan AasboLexington$451K
- Gery TomassoniLexington$196K
- John LeeLexington$139K
- David CharlesLexington$32K
- Samuel OmotoyeLexington$32K
- Yousef DarratLexington$29K
- Joel SimonLexington$23K
- Karam AyoubLexington$15K
- Ahmed NagyLexington$11K
- Kristin EllisonLexington$8K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.